Related Experiment Video
Updated: Oct 19, 2025

07:13
Alginate Encapsulation of Pluripotent Stem Cells Using a Co-axial Nozzle
Published on: July 2, 2015
12.9K
Multilayer Alginate Microcapsules For Live Cell Microencapsulation; Is There Any Preference For Selecting Cationic
Fariba Hajifathaliha1,2, Arash Mahboubi1,2, Noushin Bolourchian2
1Food Safety Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iranian Journal of Pharmaceutical Research : IJPR
|September 27, 2021
Summary
Live cell encapsulation using alginate multilayer microcapsules, particularly alginate-poly l-lysine-alginate (APA), is widely used. This review explores alternative cationic polymers to poly l-lysine (PLL) for improved cell encapsulation and clinical viability.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Cell Encapsulation Technology
Background:
- Live cell encapsulation technology, pioneered in 1980, utilizes microcapsules for cell protection and delivery.
- Alginate (Alg) multilayer microcapsules, especially alginate-poly l-lysine (PLL)-alginate (APA), are prevalent for live cell encapsulation.
- Limitations of PLL, including poor mechanical strength and biocompatibility, necessitate exploring alternative cationic polymers.
Purpose of the Study:
- To review alternative cationic polymers to PLL for live cell encapsulation.
- To evaluate the suitability of polymers like poly l-ornithine (PLO) and chitosan as replacements for PLL.
- To assess which alternative polymer systems are closest to clinical application in cell encapsulation.
Main Methods:
- Comprehensive literature review of microencapsulation techniques for live cells.
- Analysis of studies focusing on alginate-based multilayer microcapsules.
- Comparative assessment of different cationic polymers used in cell encapsulation.
Main Results:
- Alginate-poly l-lysine-alginate (APA) microcapsules are the most common structure for live cell encapsulation.
- Poly l-ornithine (PLO) and chitosan are identified as promising alternatives to PLL.
- Further research is needed to determine the clinical readiness of these alternative systems.
Conclusions:
- Alternative cationic polymers offer potential improvements over PLL in cell encapsulation.
- The selection of appropriate polymers is critical for advancing cell encapsulation towards clinical use.
- Continued investigation into biocompatibility and mechanical properties is essential for successful clinical translation.

